BLGOOTCChemicals & Allied ProductsFiscal year ends December 31
BIOLARGO, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.07+0.00 (+0.90%)
Close on Oct 19, 2026
- Market cap
- $23.27M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$0.0925 (−56.06%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.
BIOLARGO, INC. saw revenue fall 70.9% to $4.08M over the twelve months to Jun 30, 2026.
Revenue
$4.08M
-70.9% vs. a year earlier
Operating income
-$18.12M
TTM Q2 2026
EPS, diluted
-$0.05
TTM Q2 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $23.27M
- P/E ratio
- –
- Price to sales
- 5.70
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $4.08M
- EPS, diluted
- -$0.05
- Book value per share
- -$0.01
- Diluted shares
- 321M
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
$4.08M-70.9% YoY
Gross profit
$1.63M-74.4% YoY
Operating income
-$18.12M
Net income
–
EPS, diluted
-$0.05
Free cash flow
–
Reported periodTrailing twelve months